1.
Clin Pharmacol Ther
; 109(4): 810-812, 2021 04.
Article
in English
| MEDLINE | ID: covidwho-1130477
Subject(s)
Antiviral Agents/therapeutic use , COVID-19 Drug Treatment , Pharmacology, Clinical/organization & administration , Antiviral Agents/administration & dosage , Dose-Response Relationship, Drug , Drug Therapy, Combination , Evidence-Based Medicine , Humans , Microbiological Techniques , Pharmacology, Clinical/standards , SARS-CoV-2
2.
Clin Transl Sci
; 13(4): 646-648, 2020 07.
Article
in English
| MEDLINE | ID: covidwho-343680
ABSTRACT
The global response to finding therapeutics for coronavirus disease 2019 (COVID-19) is chaotic even if well intentioned. There is an opportunity, but more importantly, an obligation for the global clinical and quantitative pharmacology community to come together and use our state-of-the-art tools and expertise to help society accelerate therapeutics to fight COVID-19. This brief commentary is a call to action and highlights how the global pharmacology community should contribute to the COVID-19 pandemic and prepare for future pandemics.